584 related articles for article (PubMed ID: 9149061)
1. Increased nitric oxide production and inducible nitric oxide synthase activity in colonic mucosa of patients with active ulcerative colitis and Crohn's disease.
Kimura H; Miura S; Shigematsu T; Ohkubo N; Tsuzuki Y; Kurose I; Higuchi H; Akiba Y; Hokari R; Hirokawa M; Serizawa H; Ishii H
Dig Dis Sci; 1997 May; 42(5):1047-54. PubMed ID: 9149061
[TBL] [Abstract][Full Text] [Related]
2. Enhanced colonic nitric oxide generation and nitric oxide synthase activity in ulcerative colitis and Crohn's disease.
Rachmilewitz D; Stamler JS; Bachwich D; Karmeli F; Ackerman Z; Podolsky DK
Gut; 1995 May; 36(5):718-23. PubMed ID: 7541008
[TBL] [Abstract][Full Text] [Related]
3. Inducible nitric oxide synthase activity in colon biopsies from inflammatory areas: correlation with inflammation intensity in patients with ulcerative colitis but not with Crohn's disease.
Guihot G; Guimbaud R; Bertrand V; Narcy-Lambare B; Couturier D; Duée PH; Chaussade S; Blachier F
Amino Acids; 2000; 18(3):229-37. PubMed ID: 10901620
[TBL] [Abstract][Full Text] [Related]
4. Immunohistochemical localization of vascular endothelial growth factor in colonic mucosa of patients with inflammatory bowel disease.
Griga T; May B; Pfisterer O; Müller KM; Brasch F
Hepatogastroenterology; 2002; 49(43):116-23. PubMed ID: 11941933
[TBL] [Abstract][Full Text] [Related]
5. Obliterative arteritis with nitric oxide synthase and HLA-DR expression in Crohn's colitis.
Yokoyama K; Mitomi H; Kobayashi K; Katsumata T; Saigenji K; Okayasu I
Hepatogastroenterology; 2001; 48(38):401-7. PubMed ID: 11379318
[TBL] [Abstract][Full Text] [Related]
6. Direct determination of colonic nitric oxide level--a sensitive marker of disease activity in ulcerative colitis.
Rachmilewitz D; Eliakim R; Ackerman Z; Karmeli F
Am J Gastroenterol; 1998 Mar; 93(3):409-12. PubMed ID: 9517649
[TBL] [Abstract][Full Text] [Related]
7. Analysis of direct tissue isoelectric focused protein profiles of resected intestinal mucosa and endoscopic biopsies from patients with inflammatory bowel disease.
Szewczuk MR; Depew WT
Clin Invest Med; 1992 Feb; 15(1):49-59. PubMed ID: 1374000
[TBL] [Abstract][Full Text] [Related]
8. Increased expression of an inducible isoform of nitric oxide synthase and the formation of peroxynitrite in colonic mucosa of patients with active ulcerative colitis.
Kimura H; Hokari R; Miura S; Shigematsu T; Hirokawa M; Akiba Y; Kurose I; Higuchi H; Fujimori H; Tsuzuki Y; Serizawa H; Ishii H
Gut; 1998 Feb; 42(2):180-7. PubMed ID: 9536941
[TBL] [Abstract][Full Text] [Related]
9. Expression of nitric oxide synthase in inflammatory bowel disease is not affected by corticosteroid treatment.
Leonard N; Bishop AE; Polak JM; Talbot IC
J Clin Pathol; 1998 Oct; 51(10):750-3. PubMed ID: 10023337
[TBL] [Abstract][Full Text] [Related]
10. Nitric oxide synthase activity in ulcerative colitis and Crohn's disease.
Boughton-Smith NK; Evans SM; Hawkey CJ; Cole AT; Balsitis M; Whittle BJ; Moncada S
Lancet; 1993 Aug; 342(8867):338-40. PubMed ID: 7687730
[TBL] [Abstract][Full Text] [Related]
11. Increased production of vascular endothelial growth factor by intestinal mucosa of patients with inflammatory bowel disease.
Griga T; Voigt E; Gretzer B; Brasch F; May B
Hepatogastroenterology; 1999; 46(26):920-3. PubMed ID: 10370639
[TBL] [Abstract][Full Text] [Related]
12. Nitric oxide and inflammatory bowel diseases.
Guslandi M
Eur J Clin Invest; 1998 Nov; 28(11):904-7. PubMed ID: 9824433
[TBL] [Abstract][Full Text] [Related]
13. Increased interleukin 8 expression in the colon mucosa of patients with inflammatory bowel disease.
Daig R; Andus T; Aschenbrenner E; Falk W; Schölmerich J; Gross V
Gut; 1996 Feb; 38(2):216-22. PubMed ID: 8801200
[TBL] [Abstract][Full Text] [Related]
14. Mucosal metabolism in ulcerative colitis and Crohn's disease.
Duffy MM; Regan MC; Ravichandran P; O'Keane C; Harrington MG; Fitzpatrick JM; O'Connell PR
Dis Colon Rectum; 1998 Nov; 41(11):1399-405. PubMed ID: 9823806
[TBL] [Abstract][Full Text] [Related]
15. Serum nitrate levels in ulcerative colitis and Crohn's disease.
Oudkerk Pool M; Bouma G; Visser JJ; Kolkman JJ; Tran DD; Meuwissen SG; Peña AS
Scand J Gastroenterol; 1995 Aug; 30(8):784-8. PubMed ID: 7481547
[TBL] [Abstract][Full Text] [Related]
16. Greatly increased mucosal nitric oxide in ulcerative colitis determined in situ by a novel nitric oxide-selective microelectrode.
Iwashita E
J Gastroenterol Hepatol; 1998 Apr; 13(4):391-5. PubMed ID: 9641303
[TBL] [Abstract][Full Text] [Related]
17. Increased group II phospholipase A2 in colonic mucosa of patients with Crohn's disease and ulcerative colitis.
Minami T; Tojo H; Shinomura Y; Matsuzawa Y; Okamoto M
Gut; 1994 Nov; 35(11):1593-8. PubMed ID: 7828979
[TBL] [Abstract][Full Text] [Related]
18. Increased expression of VEGF and CD146 in patients with inflammatory bowel disease.
Tsiolakidou G; Koutroubakis IE; Tzardi M; Kouroumalis EA
Dig Liver Dis; 2008 Aug; 40(8):673-9. PubMed ID: 18374637
[TBL] [Abstract][Full Text] [Related]
19. Cyclooxygenase 2 is induced in colonic epithelial cells in inflammatory bowel disease.
Singer II; Kawka DW; Schloemann S; Tessner T; Riehl T; Stenson WF
Gastroenterology; 1998 Aug; 115(2):297-306. PubMed ID: 9679035
[TBL] [Abstract][Full Text] [Related]
20. Human beta-defensin 2 but not beta-defensin 1 is expressed preferentially in colonic mucosa of inflammatory bowel disease.
Wehkamp J; Fellermann K; Herrlinger KR; Baxmann S; Schmidt K; Schwind B; Duchrow M; Wohlschläger C; Feller AC; Stange EF
Eur J Gastroenterol Hepatol; 2002 Jul; 14(7):745-52. PubMed ID: 12169983
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
